With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
A blood test demonstrated high accuracy for detecting Alzheimer’s disease among people with cognitive symptoms, according to a study presented at the Alzheimer’s Association International Conference ...
A single blood draw and a patient’s age may be enough to estimate when Alzheimer’s disease symptoms will appear, potentially decades before memory loss begins, according to research published in ...